YellowGrade
As Biology Manufacturing Company Zymergen Implodes, Correspondence With SEC Showed Early Doubts

Aug. 3, 2021, 8:30 p.m.

(Forbes) Once backed by SoftBank Vision Fund with a blockbuster IPO in April, Zymergen announced it will have no revenue for this year or the next.

Login to grade this article.